Bo M, Carta A, Cipriani C, Cavassa V, Simula E, Huyen N
Microorganisms. 2025; 13(1).
PMID: 39858776
PMC: 11767913.
DOI: 10.3390/microorganisms13010009.
Woo H, Hwang J, Choi S, Chae S
Children (Basel). 2024; 11(5).
PMID: 38790547
PMC: 11119460.
DOI: 10.3390/children11050553.
Arkar U, Vipotnik Vesnaver T, Osredkar D, Perkovic Benedik M, Bizjak N
Front Neurol. 2024; 15:1359938.
PMID: 38585366
PMC: 10996918.
DOI: 10.3389/fneur.2024.1359938.
Etemadifar M, Abhari A, Yadegarfar G, Salari M, Ghazavi M, Rayani M
Curr J Neurol. 2023; 20(4):222-228.
PMID: 38011448
PMC: 9107569.
DOI: 10.18502/cjn.v20i4.8348.
Prajjwal P, M D M M, Natarajan B, Inban P, Gadam S, Sowndarya D
Ann Med Surg (Lond). 2023; 85(9):4433-4441.
PMID: 37663711
PMC: 10473341.
DOI: 10.1097/MS9.0000000000000930.
Clinical and Epidemiological Findings of Pediatric Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-based Study.
Nasiri E, Naseri A, Talebi M
Iran J Child Neurol. 2023; 17(3):109-119.
PMID: 37637785
PMC: 10448846.
DOI: 10.22037/ijcn.v17i2.34417.
Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada.
Yearwood C, Wilbur C
J Child Neurol. 2023; 38(5):321-328.
PMID: 37203134
PMC: 10338710.
DOI: 10.1177/08830738231176588.
The Clinical and Epidemiological Profile of Paediatric-Onset Multiple Sclerosis in Poland.
Brola W, Steinborn B, Zak M, Mazurkiewicz-Beldzinska M, Jozwiak S, Sobolewski P
J Clin Med. 2022; 11(24).
PMID: 36556109
PMC: 9785459.
DOI: 10.3390/jcm11247494.
Incidence of Pediatric Multiple Sclerosis in Iran within 2000-2019.
Nasehi M, Nikkhah A, Moosazadeh M, Saket S, Navaei R
Iran J Child Neurol. 2022; 16(1):31-38.
PMID: 35222655
PMC: 8753005.
DOI: 10.22037/ijcn.v16i1.35572.
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire).
Pilotto S, Gencarelli J, Bova S, Gerosa L, Baroncini D, Olivotto S
Mult Scler J Exp Transl Clin. 2021; 7(4):20552173211059048.
PMID: 34868629
PMC: 8640303.
DOI: 10.1177/20552173211059048.
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring.
Carta A, Zarbo I, Scoppola C, Pisuttu G, Conti M, Melis M
Mult Scler J Exp Transl Clin. 2021; 7(2):20552173211017301.
PMID: 34104473
PMC: 8165841.
DOI: 10.1177/20552173211017301.
Characteristics of pediatric multiple sclerosis: A tertiary referral center study.
Nikolic B, Ivancevic N, Zaletel I, Rovcanin B, Samardzic J, Jancic J
PLoS One. 2020; 15(12):e0243031.
PMID: 33264341
PMC: 7710048.
DOI: 10.1371/journal.pone.0243031.
Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIG study.
Arnold D, Banwell B, Bar-Or A, Ghezzi A, Greenberg B, Waubant E
J Neurol Neurosurg Psychiatry. 2020; 91(5):483-492.
PMID: 32132224
PMC: 7231437.
DOI: 10.1136/jnnp-2019-322138.
Pediatric Multiple Sclerosis: an Update.
Otallah S, Banwell B
Curr Neurol Neurosci Rep. 2018; 18(11):76.
PMID: 30229541
DOI: 10.1007/s11910-018-0886-7.
Pediatric multiple sclerosis: a review.
Alroughani R, Boyko A
BMC Neurol. 2018; 18(1):27.
PMID: 29523094
PMC: 5845207.
DOI: 10.1186/s12883-018-1026-3.
Pediatric Multiple Sclerosis in Tunisia: A Retrospective Study over 11 Years.
Ben Achour N, Rebai I, Raddadi S, Benrhouma H, Klaa H, Rouissi A
Biomed Res Int. 2017; 2017:4354826.
PMID: 29238716
PMC: 5697413.
DOI: 10.1155/2017/4354826.
Multiple Sclerosis in Pediatrics: Current Concepts and Treatment Options.
Jancic J, Nikolic B, Ivancevic N, Djuric V, Zaletel I, Stevanovic D
Neurol Ther. 2016; 5(2):131-143.
PMID: 27640189
PMC: 5130919.
DOI: 10.1007/s40120-016-0052-6.
Humoral response against host-mimetic homologous epitopes of Mycobacterium avium subsp. paratuberculosis in Japanese multiple sclerosis patients.
Cossu D, Yokoyama K, Sechi L, Otsubo S, Tomizawa Y, Momotani E
Sci Rep. 2016; 6:29227.
PMID: 27356622
PMC: 4928110.
DOI: 10.1038/srep29227.